The OneFlorida Cancer Control Alliance: Implementing the 6As in Pediatric Primary Care
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03044691|
Recruitment Status : Terminated (confounding factors impacted the ability to fully complete the aims of this study)
First Posted : February 7, 2017
Results First Posted : July 1, 2019
Last Update Posted : July 1, 2019
|Condition or disease||Intervention/treatment||Phase|
|Smoking Cessation||Behavioral: ResearchACTS software||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||84 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||The OneFlorida Cancer Control Alliance: Implementing the 6As in Pediatric Primary Care|
|Actual Study Start Date :||February 27, 2017|
|Actual Primary Completion Date :||November 11, 2017|
|Actual Study Completion Date :||November 11, 2017|
No Intervention: Control Clinic
The control group will have to complete the Adaptive Reserve and Change Process Capability Questionnaire and Clinician Survey at baseline and 9 months. Clinicians will provide their usual care related to tobacco and nicotine product use screening and cessation recommendations. Medical record of patients will be reviewed at baseline and at 6 months.
Experimental: Intervention Clinic
Participants will be asked to complete the Youth Tobacco and Nicotine Product Questionnaire and Parent Brief Questionnaire (PBQ) using the ResearchACTS software at the point of care. A follow-up survey Youth Tobacco and Nicotine Product Primary Care survey will be administered to participants at least 30 days after their clinic visit.
Behavioral: ResearchACTS software
screen patients for tobacco and nicotine product use (using the anticipate and ask components of the 6As) by having youth complete a tobacco and nicotine use screening tool using the ResearchACTS software.
- Feasibility of ResearchACTS Software in Clinical Assessment of Tobacco Use Measures [ Time Frame: Baseline ]During the recruitment period, investigators will observe feedback from patients and clinic staff on how the feasibility of using the ResearchACTS software to capture tobacco use measures in a clinical setting. Feasibility of the software tool will be demonstrated by the ability of patients to complete the assessment within the timeframe afforded during a clinical visit.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03044691
|United States, Florida|
|University of Florida Clinics|
|Gainesville, Florida, United States, 32610|
|UF Health Family Medicine and Pediatrics-Blanding|
|Jacksonville, Florida, United States, 32244|
|UF Health Family Medicine and Pediatrics-Baymeadows|
|Jacksonville, Florida, United States, 32256|
|Principal Investigator:||Elizabeth Shenkman, PhD||University of Florida|
|Principal Investigator:||Ramzi Salloum, PhD||University of Florida|